World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
77
Citations
35166
World Ranking
18253
National Ranking
9107

Steven Z. Pavletic publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Steven Z. Pavletic sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 552 publications — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Steven Z. Pavletic D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Steven Z. Pavletic sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 77 D-Index — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Steven Z. Pavletic is affiliated with the National Institutes of Health in the United States. Their research activities predominantly lie within the broad field of Medicine, with a specific focus on Hematology, Immunology, Genetics, Public Health, Environmental and Occupational Health, and Surgery.

The scientist has contributed substantially to research on topics such as Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia, Mesenchymal Stem Cell research, Acute Myeloid Leukemia, T-cell and B-cell Immunology, Renal Transplantation Outcomes and Treatments, and Childhood Cancer Survivors' Quality of Life.

Their recent scholarly output includes several papers, notable among them:

  • Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study, 2021, Blood
  • National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report, 2021, Transplantation and Cellular Therapy
  • National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report, 2021, Transplantation and Cellular Therapy
  • Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide, 2020, Biology of Blood and Marrow Transplantation
  • Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force, 2022, Transplantation and Cellular Therapy

Frequent coauthors contributing to their research include:

  • Noa G. Holtzman
  • Stephanie J. Lee
  • Edward W. Cowen
  • Corey Cutler
  • Jacqueline W. Mays

Publications by Steven Z. Pavletic are commonly found in journals such as:

  • Transplantation and Cellular Therapy
  • Blood
  • Blood Advances
  • Bone Marrow Transplantation
  • British Journal of Haematology

Best Publications

  • National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report

    Madan H. Jagasia;Hildegard T. Greinix;Mukta Arora;Kirsten M. Williams

  • National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease

    Madan H. Jagasia;Hildegard T. Greinix;Mukta Arora;Kirsten M. Williams

  • ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells

    Daniel W. Lee;Bianca D. Santomasso;Frederick L. Locke;Armin Ghobadi

  • T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma

    Jennifer N. Brudno;Irina Maric;Steven D. Hartman;Jeremy J. Rose

  • Risk factors for acute GVHD and survival after hematopoietic cell transplantation.

    Madan Jagasia;Mukta Arora;Mary E D Flowers;Nelson J. Chao

  • Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report

    Stephanie J. Lee;Daniel Wolff;Carrie Kitko;John Koreth

  • Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease

    Jennifer N. Brudno;Robert P.T. Somerville;Victoria Shi;Jeremy J. Rose

  • Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation.

    James N. Kochenderfer;Mark E. Dudley;Robert O. Carpenter;Sadik H. Kassim

  • Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.

    Howard M. Shulman;David Kleiner;Stephanie J. Lee;Thomas Morton

  • The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease.

    Kenneth R. Cooke;Leo Luznik;Stefanie Sarantopoulos;Frances T. Hakim

  • Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research

    Sally Arai;Mukta Arora;Tao Wang;Tao Wang;Stephen R. Spellman

  • Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium

    Joseph Pidala;Brenda Kurland;Xiaoyu Chai;Navneet S. Majhail

  • Randomized Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimersen Sodium (Bcl-2 antisense) in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

    Susan O'Brien;Joseph O. Moore;Thomas E. Boyd;Loree M. Larratt

  • Ancillary Therapy and Supportive Care of Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. Ancillary Therapy and Supportive Care Working Group Report

    Daniel Couriel;Paul A. Carpenter;Corey Cutler;Javier Bolaños-Meade

  • Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease

    Stephanie J. Lee;Daniel Wolff;Carrie Kitko;John Koreth

  • EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment.

    Helene M. Schoemans;Stephanie J. Lee;James L. Ferrara;Daniel Wolff

  • Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease

    Daniel Wolff;Michael Schleuning;Stephanie von Harsdorf;Ulrike Bacher

  • High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis.

    Richard A. Nash;James D. Bowen;Peter A. McSweeney;Steven Z. Pavletic

  • Consensus Conference on Clinical Practice in Chronic Graft-versus-Host Disease (GVHD): First-Line and Topical Treatment of Chronic GVHD

    Daniel Wolff;Armin Gerbitz;Francis Ayuk;Alexander Kiani

  • NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. The 2014 Pathology Working Group Report

    Howard M. Shulman;Diana M. Cardona;Joel K. Greenson;Sangeeta Hingorani;Sangeeta Hingorani;Sangeeta Hingorani

Frequent Co-Authors

Stephanie J. Lee
Stephanie J. Lee Fred Hutchinson Cancer Research Center
Ronald E. Gress
Ronald E. Gress National Institutes of Health
Seth M. Steinberg
Seth M. Steinberg National Institutes of Health
Corey Cutler
Corey Cutler Harvard University
Paul J. Martin
Paul J. Martin Fred Hutchinson Cancer Research Center
Daniel J. Weisdorf
Daniel J. Weisdorf University of Minnesota
Georgia Boyce Vogelsang
Georgia Boyce Vogelsang Johns Hopkins University
Mary M. Horowitz
Mary M. Horowitz Medical College of Wisconsin
David F. Stroncek
David F. Stroncek National Institutes of Health
Bipin N. Savani
Bipin N. Savani Vanderbilt University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens doors to many other health-related careers and online degrees. As healthcare evolves, more students are exploring online programs that offer flexibility and affordability without compromising quality.

For example, pharmd online programs allow aspiring pharmacists to earn a doctorate degree remotely, which is ideal for those looking to balance work and study. Similarly, health information technology programs online provide pathways into healthcare data management—a fast-growing field due to the digital transformation of patient records.

For students interested in the business side of healthcare, understanding medical billing and coding cost helps choose budget-friendly courses that lead to roles in healthcare administration. Additionally, those aiming to become advanced practice nurses can leverage the cheapest online fnp program options to prepare for family nurse practitioner roles.

These online degree pathways can lead to rewarding careers in healthcare without the traditional time and cost barriers of on-campus study.

Best Scientists Citing Steven Z. Pavletic

Trending Scientists

Recently Published Articles